Circulating Osteonectin as a Predictive Biomarker in Patients with Ischemic Symptomatic Chronic Heart Failure

Alexander  Berezin; Alexander A.  Kremzer

doi:10.17795/icrj-9(4)203

International Cardiovascular Research Journal

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

Home

Instructions

APC

Authors Guide Submit Manuscript

https://doi.org/10.17795/icrj-9(4)203

Circulating Osteonectin as a Predictive Biomarker in Patients with Ischemic Symptomatic Chronic Heart Failure

Author(s):

Alexander Berezin^1,*,

Alexander A. Kremzer²

1Department of Internal Medicine, State Medical University, Zaporozhye, Zaporozhye, Ukraine

2Department of Clinical Pharmacology, State Medical University, Zaporozhye, Ukraine

International Cardiovascular Research Journal:Vol. 9, issue 4; e10873

Published online:Dec 31, 2015

Article type:Research Article

Received:May 31, 2014

Accepted:Apr 22, 2015

How to Cite:Berezin A, Kremzer AA. Circulating Osteonectin as a Predictive Biomarker in Patients with Ischemic Symptomatic Chronic Heart Failure. Int Cardiovasc Res J. 2017;9(4):e10873. doi: https://doi.org/10.17795/icrj-9(4)203

Abstract

Background: Recently, some studies have revealed Osteonectin’s (OSN) promising role as a marker in cardiovascular diseases.
Objectives: This study aimed to evaluate the prognostic value of circulating OSN for cumulative survival and hospitalization in patients with ischemic Chronic Heart Failure (CHF).
Patients and Methods: This open cohort prospective study was conducted on 154 patients with ischemic symptomatic moderate-to-severe CHF at discharge from hospital. The observation period was up to 3 years (156 weeks). Blood samples for biomarker measurements were collected at baseline. ELISA method was used for measurement of OSN circulating level. Then, Receiver Operating Characteristic (ROC) curve analysis was carried out to identify the optimal cut-off points of the OSN concentration with predicted values. Odds ratios were also calculated for all the independent predictors of patients’ survival. Kaplan-Meier survival curves were also structured for both cohorts with low and high OSN levels.
Results: During a median follow-up of 2.18 years, 21 participants died and 106 subjects were hospitalized repetitively. The median of circulating OSN levels were 670.96 ng/mL (95% Confidence Interval [CI] = 636.53 - 705.35 ng/mL) and 907.84 ng/mL (95% CI = 878.02 - 937.60 ng/mL) in the survived and dead patients cohorts, respectively. Besides, ROC curve analysis showed that optimal cut-off point of OSN for cumulative survival function was 845.15 ng/mL. The results also revealed significant divergence of Kaplan-Meier survival curves in the patients with high (> 845.15 ng/mL) and low (< 845.15 ng/mL) concentrations of OSN.
Conclusions: Increased circulating OSN levels were associated with increased 3-year CHF-related death, all-cause mortality, and risk of recurrent hospitalization due to CHF.

Keywords

Fulltext

The full text is available in PDF.

References

1.
The references are available in PDF.

Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes

Alexander Berezin,

Alexander A. Kremzer,

Tatayna A. Samura,

Yulia V. Martovitskaya

Berezin A, Kremzer AA, Samura TA, Martovitskaya YV. Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes. Int Cardiovasc Res J. 2017;8(3):e11090. doi:

30

Jun

2008

Association between the level of soluble markers of Fas/FasL apoptosis system and heart failure

R Najafipour,

O Pavelovna

Najafipour R, Pavelovna O. Association between the level of soluble markers of Fas/FasL apoptosis system and heart failure. J Inflamm Dis. 2024;12(1):e155378. doi:

15

Jun

2020

Atrial Fibrillation as a Risk Marker in Patients with Decompensated Heart Failure

Maryam Nabati,

Soheil Bakhshinasab,

Ali asghar Farsavian,

Fatemeh Rasolpor,

Jamshid Yazdani- Charati

Nabati M, Bakhshinasab S, Farsavian AA, Rasolpor F, Yazdani- Charati J. Atrial Fibrillation as a Risk Marker in Patients with Decompensated Heart Failure. Int Cardiovasc Res J. 2020;14(2):e103597. doi:

1

Dec

2014

Assessment of the Relationship between Galectin-3 and Ejection Fraction and Functional Capacity in the Patients with Compensated Systolic Heart Failure

Roya Atabakhshian,

Faranak Kazerouni,

Fariba Raygan,

Hushang Amirrasouli,

Ali Rahimipour,

Nezhat Shakeri

Atabakhshian R, Kazerouni F, Raygan F, Amirrasouli H, Rahimipour A, et al. Assessment of the Relationship between Galectin-3 and Ejection Fraction and Functional Capacity in the Patients with Compensated Systolic Heart Failure. Int Cardiovasc Res J. 2017;8(4):e11675. doi:

1

Dec

2019

Correlates and Prognostic Value of NT-proBNP in Post-Acute Coronary Syndrome Patients with Preserved Left Ventricular Ejection Fraction

Marta Fontes-Oliveira,

Filipe Martins,

Luis Gomes,

Maria Trepa,

Raquel Baggen-Santos,

Ricardo Costa

,et al.

Fontes-Oliveira M, Martins F, Gomes L, Trepa M, Baggen-Santos R, et al. Correlates and Prognostic Value of NT-proBNP in Post-Acute Coronary Syndrome Patients with Preserved Left Ventricular Ejection Fraction. Int Cardiovasc Res J. 2019;13(4):e96017. doi:

Import into EndNote Import into BibTex

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 1 month ago
Scopus by Title: 0
Last Update: 1 month ago
Scopus by Title (Ref): 0
Last Update: 1 month ago
CrossRef: 0
Last Update: 1 day ago

Metrics

Licensing and reuse information

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Alexander Berezin:[PubMed][Scholar]
Alexander A. Kremzer:[PubMed][Scholar]

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

Outlines

Circulating Osteonectin as a Predictive Biomarker in Patients with Ischemic Symptomatic Chronic Heart Failure

Abstract

Fulltext

References

Similar Articles

Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes

Association between the level of soluble markers of Fas/FasL apoptosis system and heart failure

Atrial Fibrillation as a Risk Marker in Patients with Decompensated Heart Failure

Assessment of the Relationship between Galectin-3 and Ejection Fraction and Functional Capacity in the Patients with Compensated Systolic Heart Failure

Correlates and Prognostic Value of NT-proBNP in Post-Acute Coronary Syndrome Patients with Preserved Left Ventricular Ejection Fraction

Crossmark

Checking

Last Update: 1 month ago

Last Update: 1 month ago

Last Update: 1 month ago

Last Update: 1 day ago